| Year |
Citation |
Score |
| 2013 |
Le Maître E, Dourmap N, Vilpoux C, Leborgne R, Janin F, Bonnet JJ, Costentin J, Leroux-Nicollet I. Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin/NOP system and serotonin. Brain Research. 1520: 51-60. PMID 23669068 DOI: 10.1016/J.Brainres.2013.05.005 |
0.328 |
|
| 2004 |
Legros H, Dingeval MG, Janin F, Costentin J, Bonnet JJ. Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: relationships with 3,4-dihydroxyphenylacetaldehyde formation. Neurotoxicology. 25: 365-75. PMID 15019299 DOI: 10.1016/S0161-813X(03)00148-7 |
0.349 |
|
| 2004 |
Legros H, Janin F, Dourmap N, Bonnet JJ, Costentin J. Semi-chronic increase in striatal level of 3,4-dihydroxyphenylacetaldehyde does not result in alteration of nigrostriatal dopaminergic neurones. Journal of Neuroscience Research. 75: 429-35. PMID 14743456 DOI: 10.1002/Jnr.10880 |
0.32 |
|
| 2003 |
Bonnet JJ. Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter. European Journal of Pharmacology. 479: 199-212. PMID 14612150 |
0.631 |
|
| 2001 |
Syringas M, Janin F, Giros B, Costentin J, Bonnet JJ. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake. British Journal of Pharmacology. 133: 387-94. PMID 11375255 DOI: 10.1038/Sj.Bjp.0704097 |
0.524 |
|
| 2001 |
Tidjane Corera A, Do-Régo JC, Costentin J, Bonnet JJ. Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes. Neuroscience Research. 39: 319-25. PMID 11248372 DOI: 10.1016/S0168-0102(00)00230-3 |
0.655 |
|
| 2000 |
Syringas M, Janin F, Mezghanni S, Giros B, Costentin J, Bonnet JJ. Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na(+)- and Cl(-)-dependence of dopamine transport. Molecular Pharmacology. 58: 1404-11. PMID 11093780 DOI: 10.1124/Mol.58.6.1404 |
0.467 |
|
| 2000 |
Corera AT, Costentin J, Bonnet JJ. Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements. Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 213-21. PMID 10997723 DOI: 10.1007/S002100000280 |
0.802 |
|
| 1999 |
Régo JC, Syringas M, Leblond B, Costentin J, Bonnet JJ. Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat. British Journal of Pharmacology. 128: 51-60. PMID 10498834 DOI: 10.1038/Sj.Bjp.0702784 |
0.577 |
|
| 1999 |
Do-Régo JC, Hue H, Costentin J, Bonnet JJ. Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine. Journal of Neurochemistry. 72: 396-404. PMID 9886093 DOI: 10.1046/J.1471-4159.1999.0720396.X |
0.58 |
|
| 1996 |
Thibaut F, Bonnet JJ, Vaugeois JM, Costentin J. Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [3H]mazindol or [3H]cocaine in mice. Neuroscience Letters. 205: 145-8. PMID 8852579 DOI: 10.1016/0304-3940(96)12399-5 |
0.49 |
|
| 1996 |
Thibaut F, Vaugeois JM, Bonnet JJ, Costentin J. In vivo striatal binding of the D1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission. Neuropharmacology. 35: 267-72. PMID 8783200 DOI: 10.1016/0028-3908(95)00187-5 |
0.571 |
|
| 1996 |
Héron C, Billaud G, Costentin J, Bonnet JJ. Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier. European Journal of Pharmacology. 301: 195-202. PMID 8773464 DOI: 10.1016/0014-2999(96)00050-7 |
0.608 |
|
| 1996 |
Corera AT, Costentin J, Bonnet JJ. Effect of low concentrations of K+ and Cl- on the Na(+)-dependent neuronal uptake of [3H] dopamine. Naunyn-Schmiedeberg's Archives of Pharmacology. 353: 610-5. PMID 8738293 DOI: 10.1007/Bf00167179 |
0.778 |
|
| 1995 |
Naudin B, Bonnet JJ, Costentin J. Acute L-DOPA pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice. Brain Research. 701: 151-7. PMID 8925278 DOI: 10.1016/0006-8993(95)00988-7 |
0.426 |
|
| 1995 |
Refahi-Lyamani F, Saadouni S, Costentin J, Bonnet JJ. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites. Naunyn-Schmiedeberg's Archives of Pharmacology. 351: 136-45. PMID 7770096 DOI: 10.1007/Bf00169327 |
0.573 |
|
| 1994 |
Bonnet JJ, Benmansour S, Amejdki-Chab N, Costentin J. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+. European Journal of Pharmacology. 266: 87-97. PMID 8137886 DOI: 10.1016/0922-4106(94)90213-5 |
0.719 |
|
| 1994 |
Saadouni S, Refahi-Lyamani F, Costentin J, Bonnet JJ. Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier. European Journal of Pharmacology. 268: 187-97. PMID 7957640 DOI: 10.1016/0922-4106(94)90188-0 |
0.598 |
|
| 1994 |
Billaud G, Menard JF, Marcellin N, Kamenka JM, Costentin J, Bonnet JJ. Thermodynamics of the binding of BTCP (GK 13) and related derivatives on the dopamine neuronal carrier. European Journal of Pharmacology. 268: 357-63. PMID 7805759 DOI: 10.1016/0922-4106(94)90060-4 |
0.607 |
|
| 1994 |
Héron C, Costentin J, Bonnet JJ. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier. European Journal of Pharmacology. 264: 391-8. PMID 7698180 DOI: 10.1016/0014-2999(94)00502-8 |
0.638 |
|
| 1993 |
Vaugeois JM, Bonnet JJ, Duterte-Boucher D, Costentin J. In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion. European Journal of Pharmacology. 230: 195-201. PMID 8422901 DOI: 10.1016/0014-2999(93)90802-O |
0.419 |
|
| 1993 |
Billaud G, Costentin J, Bonnet JJ. Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes. European Journal of Pharmacology. 247: 333-40. PMID 8307105 DOI: 10.1016/0922-4106(93)90203-L |
0.691 |
|
| 1992 |
Amejdki-Chab N, Costentin J, Bonnet JJ. Kinetic analysis of the chloride dependence of the neuronal uptake of dopamine and effect of anions on the ability of substrates to compete with the binding of the dopamine uptake inhibitor GBR 12783. Journal of Neurochemistry. 58: 793-800. PMID 1737991 DOI: 10.1111/J.1471-4159.1992.Tb09327.X |
0.725 |
|
| 1992 |
Amejdki-Chab N, Benmansour S, Costentin J, Bonnet JJ. Effects of several cations on the neuronal uptake of dopamine and the specific binding of [3H]GBR 12783: attempts to characterize the Na+ dependence of the neuronal transport of dopamine. Journal of Neurochemistry. 59: 1795-804. PMID 1402923 DOI: 10.1111/J.1471-4159.1992.Tb11012.X |
0.74 |
|
| 1992 |
Vaugeois JM, Bonnet JJ, Costentin J. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783. European Journal of Pharmacology. 210: 77-84. PMID 1350989 DOI: 10.1016/0014-2999(92)90654-M |
0.595 |
|
| 1990 |
Vaugeois JM, Bonnet JJ, Costentin J. Relationship between the effects of dexamphetamine on locomotion and on striatal [3H]GBR 12783 binding in vivo. European Journal of Pharmacology. 178: 221-7. PMID 2328762 DOI: 10.1016/0014-2999(90)90478-O |
0.503 |
|
| 1989 |
Bonnet JJ, Costentin J. Correlation between (3H)dopamine specific uptake and (3H)GBR 12783 specific binding during the maturation of rat striatum. Life Sciences. 44: 1759-65. PMID 2733550 DOI: 10.1016/0024-3205(89)90563-8 |
0.611 |
|
| 1989 |
Thibaut F, Bonnet JJ, Costentin J. Time course of postmortem modifications in synaptosomal [3H]dopamine uptake and [3H]GBR 12783 binding to the dopamine uptake complex in the rat striatum. Neuroscience Letters. 96: 335-9. PMID 2717059 DOI: 10.1016/0304-3940(89)90401-1 |
0.555 |
|
| 1988 |
Bonnet JJ, Benmansour S, Vaugeois JM, Costentin J. Ionic requirements for the specific binding of [3H]GBR 12783 to a site associated with the dopamine uptake carrier. Journal of Neurochemistry. 50: 759-65. PMID 3339350 DOI: 10.1111/J.1471-4159.1988.Tb02979.X |
0.65 |
|
| 1987 |
Chagraoui A, Bonnet JJ, Protais P, Costentin J. In vivo binding of [3H]GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum. Neuroscience Letters. 78: 175-9. PMID 3627558 DOI: 10.1016/0304-3940(87)90629-X |
0.596 |
|
| 1987 |
Bonnet JJ, Chagraoui A, Protais P, Costentin J. Interactions of amineptine with the neuronal dopamine uptake system: neurochemical in vitro and in vivo studies. Journal of Neural Transmission. 69: 211-20. PMID 3625193 DOI: 10.1007/BF01244342 |
0.586 |
|
| 1987 |
Benmansour S, Bonnet JJ, Protais P, Costentin J. Sodium independence of the binding of [3H]GBR 12783 and other dopamine uptake inhibitors to the dopamine uptake complex. Neuroscience Letters. 77: 97-102. PMID 3601221 DOI: 10.1016/0304-3940(87)90614-8 |
0.689 |
|
| 1986 |
Bonnet JJ, Costentin J. GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo. European Journal of Pharmacology. 121: 199-209. PMID 3754516 DOI: 10.1016/0014-2999(86)90491-7 |
0.59 |
|
| 1986 |
Bonnet JJ, Protais P, Chagraoui A, Costentin J. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system. European Journal of Pharmacology. 126: 211-22. PMID 3489625 DOI: 10.1016/0014-2999(86)90050-6 |
0.672 |
|
| 1984 |
Lemasson MH, Bonnet JJ, Costentin J. Artefactual inhibition of dopamine uptake by psychotropic drugs on striatal synaptosomal preparation. Biochemical Pharmacology. 33: 2137-41. PMID 6743358 DOI: 10.1016/0006-2952(84)90584-7 |
0.565 |
|
| 1984 |
Bonnet JJ, Lemasson MH, Costentin J. Simultaneous evaluation by a double labelling method of drug-induced uptake inhibition and release of dopamine in synaptosomal preparation of rat striatum. Biochemical Pharmacology. 33: 2129-35. PMID 6743357 DOI: 10.1016/0006-2952(84)90583-5 |
0.476 |
|
| 1978 |
Pollard H, Llorens C, Bonnet JJ, Costentin J, Schwartz JC. Opiate receptors on mesolimbic dopaminergic neurons. Neuroscience Letters. 7: 295-9. PMID 19605129 DOI: 10.1016/0304-3940(78)90216-1 |
0.393 |
|
| Show low-probability matches. |